Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$862K Sell
30,686
-2,664
-8% -$70.9K 0.02% 446
2025
Q4
$830K Sell
33,350
-7,144
-18% -$180K 0.03% 392
2025
Q3
$1.03M Buy
40,494
+6,519
+19% +$161K 0.03% 382
2025
Q2
$824K Sell
33,975
-61,707
-64% -$1.44M 0.02% 382
2025
Q1
$2.42M Buy
95,682
+54,129
+130% +$1.42M 0.12% 144
2024
Q4
$1.1M Buy
+41,553
New +$1.13M 0.06% 210

Other funds holding PFE

SIG Brokerage's PFE Position: Q1 2026 in Review

SIG Brokerage reduced its Pfizer (PFE) stake by 8% in Q1 2026, selling an estimated $70.9K and leaving 30,686 shares worth $862K. The position accounts for 0.02% of the portfolio, ranked #446.

SIG Brokerage first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.42M in Q1 2025. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SIG Brokerage held 30,686 shares of Pfizer worth $862K as of Q1 2026.
  • SIG Brokerage sold 2,664 Pfizer shares in Q1 2026, an estimated $70.9K.
  • Pfizer made up 0.02% of SIG Brokerage's portfolio in Q1 2026, its #446 holding.
  • SIG Brokerage first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • SIG Brokerage's Pfizer position peaked at $2.42M in Q1 2025.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.